Clinical Review
UPDATE ON CERVICAL DISEASE
Guidelines have changed again, of necessity. Here is a roundup of the major alterations and new guidance.
Deborah Reale, Managing Editor
Recognizing that gynecologists have a long tradition of screening for and treating sexually transmitted diseases in both women and men, the American Board of Obstetrics and Gynecology clarifies the role of the gynecologist in male patient care
When the American Board of Obstetrics and Gynecology (ABOG) announced in September that, with a few exceptions, gynecologists could lose their board certification if they treated men, gynecologists were forced to stop treating male patients. This decision has now been altered, and gynecologists are now allowed to treat male patients for sexually transmitted diseases (STDs) and to screen men for anal cancer.1
Experts in anal cancer and patient advocacy groups lobbied ABOG to revise their position based on gynecologists’ long-standing tradition of treating men and women for STDs. Anal cancer is usually caused by human papillomavirus. Although rare, the incidence of anal cancer is increasing, especially among those infected with human immunodeficiency virus.1
ABOG’s new statement reads2:
To remain certified by ABOG the care of male patients is prohibited except in the
following circumstances:
Mark H. Einstein, MD, professor in the Department of Obstetrics and Gynecology and Women’s Health at Montefiore Medical Center in Bronx, New York, and author of “Update on Cervical Disease” (OBG Management, May 2013), was forced to discontinue seeing male patients. He commented, “Cool heads have prevailed. This is the best decision for our patients.”1
We want to hear from you. Tell us what you think!
Guidelines have changed again, of necessity. Here is a roundup of the major alterations and new guidance.
Primary care interventions vary with the age of the patient, but there are similarities, too. A look at recommendations for four age intervals: 13...
Start using combination therapy with ceftriaxone and either azithromycin or doxycycline because of increasing resistance to oral cephalosporins....
Will co-testing further reduce your patients’ risk of cervical Ca, compared with current Pap screening alone? How should you care for a woman who...